FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

OurPharma FentaNYL Citrate 2 Recall

FentaNYL Citrate 2

OurPharma LLC · Fayetteville, AR

Risk level
Class III
Reported by FDA
Feb 1, 2023
Recall ID
D-0172-2023
Check your lot numberHow we source this data

Summary

OurPharma recalled FentaNYL Citrate 2 starting Jan 13, 2023. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-0172-2023 on Feb 1, 2023. Reason: Short Fill: Underfilled units. Status: Terminated.

Why it was recalled

Short Fill: Underfilled units.

Product description

FentaNYL Citrate 2.5mg/50mL (50mcg/mL) Injection Solution, Preservative-Free IV Injection 50mL Cassette, Rx Only, OurPharma, LLC, 2512 S. City Lake Rd., Fayetteville, AR 72701, NDC 73013-1001-01.

Lot numbers, UPCs & expiration codes

Lots: 100122080003, Exp. 2/26/2023; 100122090001, Exp. 3/07/2023; 100122100002, Exp. 4/05/2023

Where it was sold

IL and MO

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0172-2023
Classification
Class III
Status
Terminated
Recall initiated
Jan 13, 2023
FDA report date
Feb 1, 2023
Quantity
768 cassettes
Recall type
Voluntary: Firm initiated
Recalling firm
OurPharma LLC

Original FDA data

Every field from FDA enforcement report D-0172-2023, exactly as published.

Show all FDA fields
City
Fayetteville
State
AR
Status
Terminated
Country
United States
Event ID
91520
Address
2512 S City Lake Rd
Code information
Lots: 100122080003, Exp. 2/26/2023; 100122090001, Exp. 3/07/2023; 100122100002, Exp. 4/05/2023
Postal code
72701-5013
Report date
Feb 1, 2023
Product type
Drugs
Recall number
D-0172-2023
Classification
Class III
Recalling firm
OurPharma LLC
Product quantity
768 cassettes
Termination date
Sep 20, 2024
Reason for recall
Short Fill: Underfilled units.
Voluntary / mandated
Voluntary: Firm initiated
Product description
FentaNYL Citrate 2.5mg/50mL (50mcg/mL) Injection Solution, Preservative-Free IV Injection 50mL Cassette, Rx Only, OurPharma, LLC, 2512 S. City Lake Rd., Fayetteville, AR 72701, NDC 73013-1001-01.
Distribution pattern
IL and MO
Recall initiation date
Jan 13, 2023
Initial firm notification
Letter
Center classification date
Jan 23, 2023

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0172-2023, published Feb 1, 2023. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls